• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults.

作者信息

Bauer L A, Davis R, Wilensky A, Raisys V, Levy R H

出版信息

Clin Pharmacol Ther. 1985 Jun;37(6):697-700. doi: 10.1038/clpt.1985.116.

DOI:10.1038/clpt.1985.116
PMID:3924464
Abstract

Six young (22 to 25 years old) and six elderly (60 to 88 years old) healthy adults took valproic acid, 250 mg by mouth, at 8 am and 8 pm for 5 days. On the fifth day, blood samples were drawn over each dosage interval. Both young and elderly subjects exhibited diurnal variability. Total and unbound clearances in the young and elderly subjects were about 10% and 15% higher during the evening. These changes led to lower total and unbound steady-state and peak concentrations during the nighttime dosage interval. There were no differences in total steady-state concentrations and kinetics computed from total concentrations between the young and elderly, but there were differences in unbound steady-state concentrations and kinetics. Unbound clearances were 65% lower, which resulted in unbound steady-state concentrations 67% higher in the elderly. The average unbound fractions in the elderly and young were 10.7% and 6.4%. To minimize the influence of diurnal variability, drug concentrations should be determined at the same time each day. Total valproic acid concentration data may be less useful in elderly patients; unbound concentrations may be more reliable in this population.

摘要

相似文献

1
Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults.
Clin Pharmacol Ther. 1985 Jun;37(6):697-700. doi: 10.1038/clpt.1985.116.
2
Diurnal variation in valproic acid clearance.丙戊酸清除率的昼夜变化。
Clin Pharmacol Ther. 1984 Apr;35(4):505-9. doi: 10.1038/clpt.1984.68.
3
Dose-related pharmacokinetics and pharmacodynamics of valproate in the elderly.
J Clin Psychopharmacol. 2003 Oct;23(5):471-8. doi: 10.1097/01.jcp.0000088903.24613.2a.
4
Pharmacokinetics of valproic acid in the elderly.丙戊酸在老年人中的药代动力学
Br J Clin Pharmacol. 1984 Jun;17(6):665-9. doi: 10.1111/j.1365-2125.1984.tb02401.x.
5
Nonstationary disposition of valproic acid during prolonged intravenous infusion: contributions of unbound clearance and protein binding.丙戊酸在长时间静脉输注期间的非稳态处置:游离清除率和蛋白结合的作用
Biopharm Drug Dispos. 2001 Sep;22(6):243-9. doi: 10.1002/bdd.259.
6
Pharmacokinetics of valproic acid in young and elderly subjects.丙戊酸在年轻和老年受试者中的药代动力学。
Br J Clin Pharmacol. 1983 Jul;16(1):104-5. doi: 10.1111/j.1365-2125.1983.tb02151.x.
7
Unbound valproate fraction in plasma and subcutaneous microdialysate in steady state and after a single dose in humans.人体在稳态及单次给药后血浆和皮下微透析液中游离丙戊酸的比例。
Ther Drug Monit. 2003 Jun;25(3):378-83. doi: 10.1097/00007691-200306000-00020.
8
Can the serum protein binding of valproic acid limit the hepatic elimination?丙戊酸的血清蛋白结合会限制其肝脏清除吗?
Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):529-32.
9
Effect of unbound clearance on binding parameters of valproic acid to serum proteins.
J Clin Pharmacol. 1993 Feb;33(2):130-5. doi: 10.1002/j.1552-4604.1993.tb03932.x.
10
Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.癫痫患儿中总丙戊酸和游离丙戊酸的药代动力学参数及其与癫痫控制的关系。
Am J Ther. 2006 May-Jun;13(3):211-7. doi: 10.1097/01.mjt.0000155113.89092.58.

引用本文的文献

1
A Clinical Nomogram for Predicting Substandard Serum Valproic Acid Concentrations in Chinese Patients With Epilepsy.预测中国癫痫患者血清丙戊酸浓度不达标的临床列线图
Curr Ther Res Clin Exp. 2024 Dec 26;102:100771. doi: 10.1016/j.curtheres.2024.100771. eCollection 2025.
2
Antiepileptic drugs in critically ill patients.重症患者的抗癫痫药物。
Crit Care. 2018 Jun 7;22(1):153. doi: 10.1186/s13054-018-2066-1.
3
A systematic review of population pharmacokinetics of valproic acid.丙戊酸群体药代动力学的系统评价。
Br J Clin Pharmacol. 2018 May;84(5):816-834. doi: 10.1111/bcp.13510. Epub 2018 Feb 28.
4
Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.年龄、性别及CYP2C9/2C19基因多态性对丙戊酸剂量校正稳态血药浓度的影响——一项基于自然状态下治疗药物监测数据的大规模研究
Eur J Clin Pharmacol. 2016 Sep;72(9):1099-104. doi: 10.1007/s00228-016-2087-0. Epub 2016 Jun 29.
5
A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.癫痫患儿丙戊酸的群体药代动力学模型:基于蛋白结合饱和的非线性药代动力学模型。
Clin Pharmacokinet. 2015 Mar;54(3):305-17. doi: 10.1007/s40262-014-0212-8.
6
Variability of carbamazepine and valproate concentrations in elderly nursing home residents.老年养老院居民中卡马西平和丙戊酸浓度的变化。
Epilepsy Res. 2012 Aug;101(1-2):22-7. doi: 10.1016/j.eplepsyres.2012.02.014. Epub 2012 Mar 30.
7
Apparent clearance of valproic acid in elderly epileptic patients: estimation of the confounding effect of albumin concentration.老年癫痫患者中丙戊酸的表观清除率:白蛋白浓度混杂效应的估计。
Ups J Med Sci. 2012 Mar;117(1):41-6. doi: 10.3109/03009734.2011.640412. Epub 2011 Dec 29.
8
The 'apparent clearance' of free phenytoin in elderly vs. younger adults.老年人与年轻人相比游离苯妥英的“表观清除率”。
Br J Clin Pharmacol. 2010 Jul;70(1):132-8. doi: 10.1111/j.1365-2125.2010.03673.x.
9
Free drug metabolic clearance in elderly people.老年人的游离药物代谢清除率。
Clin Pharmacokinet. 2008;47(5):297-321. doi: 10.2165/00003088-200847050-00002.
10
Drug treatment of epilepsy in elderly people: focus on valproic Acid.老年人癫痫的药物治疗:聚焦丙戊酸
Drugs Aging. 2003;20(2):141-52. doi: 10.2165/00002512-200320020-00005.